Restricted Distribution Patent Claims ‎Are Not Method-of-Using Claims for the Purpose of ‎‎Listing in ‎FDA's Orange Book | Locke Lord LLP
In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc....